27 I) Historique de la greffe de cellules souches hématopoïétiques27 II) Déroulement de l28 A), p.29 ,
29 C) La prise du greffon31 IV) Résultats de l'allogreffe31 A)31 A.1) Les antigènes mineurs d'histocompatibilités, .32 A.3) Les lymphocytes Natural Killer, p.32 ,
35 E) Les complications principales, p.36 ,
47 F.1) Reconstitution immunitaire, 47 F.2) Les infections en post, p.48 ,
50 A) Cellules nucléées totales50 B) Cellules souches hématopoïétiques, 50 B.2) Les cellules souches hématopoïétiques, p.52 ,
59 A)59 B) Les étapes de la reprise de l'hématopoïèse après la greffe, 60 C) Les manipulations du, p.60 ,
68 II)68 A), .68 C) Choix du type de greffon : moelle versus CSP, p.68 ,
68 A)69 C) Les prophylaxies anti-infectieuses, ., vol.68, p.69 ,
69 A) Prélèvement médullaire au bloc opératoire69 B) Manipulation sur le greffon, Désérythrocytation, p.70 ,
73 A) Reconstitution hématopoïétique73 B)73 C) Erreur ! Signet non défini. E) MVO, MAT, syndrome de fuite capillaire et syndrome de prise de greffe, .74 G) La mortalité liée à la greffe, p.74 ,
76 II) Description du greffon79 A) Composition79 B) Impact des caractéristiques pré-greffe sur la composition du greffon, .80 D) Lien entre les différents types de cellules, p.83 ,
84 A)84 B) Reconstitution hématopoïétique, 88 B.4) Patients avec la reconstitution en PNN et en plaquettes la plus lente, p.90 ,
118 III) Impact du conditionnement, IV), p.119 ,
015x10 8 /kg CNT, on observe significativement (p=0.0307) plus d'infection bactérienne Pour les CD34+, en cas de greffon comportant moins de 1.93x10 6 /kg ou moins de 3.47x10 6 /kg on observe significativement (p=0.0169 et p=0.0475 respectivement) plus d'infection bactérienne. Pour les CFU-GM, en cas de greffon comportant moins de 53 ,
Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication, Br Med J. 15 sept, vol.2, issue.4993, pp.626-627, 1956. ,
Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy, N Engl J Med. 12 sept, vol.257, issue.11, pp.491-496, 1957. ,
Adoptive immunotherapy of acute leukemia: experimental and clinical results, Cancer Res. oct, vol.25, issue.9, pp.1525-1531, 1965. ,
Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling, New England Journal of Medicine, vol.321, issue.17, pp.1174-1178, 1989. ,
DOI : 10.1056/NEJM198910263211707
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, Blood, vol.97, issue.11, pp.3390-3400, 2001. ,
DOI : 10.1182/blood.V97.11.3390
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors, New England Journal of Medicine, vol.367, issue.16, pp.1487-1496, 2012. ,
DOI : 10.1056/NEJMoa1203517
URL : http://europepmc.org/articles/pmc3816375?pdf=render
Unmanipulated haploidentical transplants compared with other alterntive donors and matched sibling graft : a single centre experience in 488 patients ,
Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: ???what is the best recipe????, Bone Marrow Transplantation, vol.101, issue.Suppl. 1, pp.565-574, 2005. ,
DOI : 10.1182/blood-2002-05-1340
Graft-versusleukemia reactions after bone marrow transplantation, Blood. 1 févr, vol.75, issue.3, pp.555-562, 1990. ,
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens, Nature Medicine, vol.6, issue.4, pp.410-414, 2002. ,
DOI : 10.1038/79573
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report, Biology of Blood and Marrow Transplantation, vol.11, issue.12, pp.945-956, 2005. ,
DOI : 10.1016/j.bbmt.2005.09.004
The Immunopathophysiology of Acute Graft‐Versus‐Host‐Disease, Stem Cells, vol.86, issue.5, pp.473-489, 1996. ,
DOI : 10.7326/0003-4819-89-6-893
Pathophysiology of Graft-Versus-Host Disease, Seminars in Hematology, vol.43, issue.1, pp.3-10, 2006. ,
DOI : 10.1053/j.seminhematol.2005.09.001
A Revision of Billingham???s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.12, issue.1, pp.2-8, 2006. ,
DOI : 10.1016/j.bbmt.2005.09.015
CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S, Transplantation, vol.18, issue.4, pp.295-304, 1974. ,
DOI : 10.1097/00007890-197410000-00001
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation, vol.18, issue.8, pp.1150-1163, 2012. ,
DOI : 10.1016/j.bbmt.2012.04.005
Biology of Chronic Graft-versus-Host Disease: Implications for a Future Therapeutic Approach, The Keio Journal of Medicine, vol.57, issue.4, pp.177-183, 2008. ,
DOI : 10.2302/kjm.57.177
Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues, Biology of Blood and Marrow Transplantation, vol.14, issue.4, pp.365-378, 2008. ,
DOI : 10.1016/j.bbmt.2007.12.002
Les complications pulmonaires tardives non infectieuses apr??s allogreffe de cellules souches h??matopo????tiques, Revue des Maladies Respiratoires, vol.25, issue.2, pp.173-183, 2008. ,
DOI : 10.1016/S0761-8425(08)71515-8
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 ,
Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD, Biology of Blood and Marrow Transplantation, vol.16, issue.12, pp.1611-1628, 2010. ,
DOI : 10.1016/j.bbmt.2010.06.015
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.17, issue.1, pp.1-17, 2011. ,
DOI : 10.1016/j.bbmt.2010.05.011
Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy, Biology of Blood and Marrow Transplantation, vol.14, issue.10, pp.1163-1171, 2008. ,
DOI : 10.1016/j.bbmt.2008.07.015
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy, British Journal of Haematology, vol.118, issue.2, pp.279-280, 2013. ,
DOI : 10.1182/blood-2011-02-321315
Immune restoration following hematopoietic stem cell transplantation: an evolving target, Bone Marrow Transplantation, vol.103, issue.Suppl. 1, pp.835-857, 2005. ,
DOI : 10.1182/blood-2003-11-4041
URL : http://www.nature.com/bmt/journal/v35/n9/pdf/1704966a.pdf
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation, J Immunol Baltim Md août, vol.181, issue.13, pp.2227-2237, 1950. ,
Delivery of progenitors to the thymus limits T-lineage reconstitution after bone marrow transplantation, Blood, vol.118, issue.7, 2011. ,
DOI : 10.1182/blood-2010-12-324954
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation, Blood, vol.97, issue.5, pp.1458-1466, 2001. ,
DOI : 10.1182/blood.V97.5.1458
URL : http://www.bloodjournal.org/content/bloodjournal/97/5/1458.full.pdf
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time, Bone Marrow Transplantation, vol.100, issue.Suppl 2, pp.757-769, 2005. ,
DOI : 10.1182/blood-2002-03-0801
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biology of Blood and Marrow Transplantation, vol.15, issue.10, pp.1143-1238, 2009. ,
DOI : 10.1016/j.bbmt.2009.06.019
Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors, Nature, vol.364, issue.6432, pp.67-70, 1993. ,
DOI : 10.1038/364067a0
Embryonic origin of human hematopoiesis, The International Journal of Developmental Biology, vol.54, issue.6-7, pp.6-71061, 2010. ,
DOI : 10.1387/ijdb.103097mt
Emergence of the haematopoietic system in the human embryo and foetus, Haematologica. juin, vol.84, 1999. ,
Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells, Nature. 2 févr, vol.197, pp.452-454, 1963. ,
The repopulating potential and differentiation capacity of hematopoietic stem cells from the blood and bone marrow of normal mice, Journal of Cellular Physiology, vol.150, issue.2, pp.121-132, 1968. ,
DOI : 10.3181/00379727-103-25470
The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice, Radiat Res. juill, vol.13, pp.115-125, 1960. ,
Limiting Factors in Murine Hematopoietic Stem Cell Assays, Cell Stem Cell, vol.1, issue.3, pp.263-270, 2007. ,
DOI : 10.1016/j.stem.2007.08.016
Purification and characterization of mouse hematopoietic stem cells, Science, vol.241, issue.4861, pp.58-62, 1988. ,
DOI : 10.1126/science.2898810
Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow, Journal of Experimental Medicine, vol.175, issue.1, pp.175-184, 1992. ,
DOI : 10.1084/jem.175.1.175
Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation., Proceedings of the National Academy of Sciences, vol.89, issue.4, pp.1502-1506, 1992. ,
DOI : 10.1073/pnas.89.4.1502
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell, Science, vol.273, issue.5272, pp.242-245, 1996. ,
DOI : 10.1126/science.273.5272.242
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo, Journal of Experimental Medicine, vol.183, issue.4, pp.1797-1806, 1996. ,
DOI : 10.1084/jem.183.4.1797
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells, J Immunol Baltim Md juill, vol.133, issue.1, pp.157-165, 1950. ,
CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009, Transfusion, vol.180, issue.1, pp.2046-2056, 2009. ,
DOI : 10.4049/jimmunol.180.8.5645
Functional differences between CD38-and DR-subfractions of CD34+ bone marrow cells, Blood. 1 sept, vol.84, issue.5, pp.1473-1481, 1994. ,
CD34: structure, biology, and clinical utility, Blood. 1 janv, vol.87, issue.1, pp.1-13, 1996. ,
Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells, Blood. 1 juin, vol.85, issue.11, pp.3040-3047, 1995. ,
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry, Journal of Hematotherapy, vol.5, issue.3, pp.213-226, 1996. ,
DOI : 10.1089/scd.1.1996.5.213
The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells and unwitting host to molecular parasites, Leukemia, vol.21, issue.5, pp.941-950, 2008. ,
DOI : 10.3181/00379727-140-36426
Bone-marrow haematopoietic-stem-cell niches, Nature Reviews Immunology, vol.89, issue.2, pp.93-106, 2006. ,
DOI : 10.1038/nature04247
Immunohematologic Problems Associated With Bone Marrow Transplantation, Transfusion Medicine Reviews, vol.1, issue.2, pp.85-100, 1987. ,
DOI : 10.1016/S0887-7963(87)70009-1
Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion, Blood. août, vol.60, issue.2, pp.420-425, 1982. ,
The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes, Biology of Blood and Marrow Transplantation, vol.16, issue.2, pp.253-262, 2010. ,
DOI : 10.1016/j.bbmt.2009.10.004
Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery, Journal of Hematotherapy, vol.5, issue.6, pp.663-670, 1996. ,
DOI : 10.1089/scd.1.1996.5.663
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy, Blood. 15 nov, vol.86, issue.10, pp.3961-3969, 1995. ,
Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation., Journal of Clinical Oncology, vol.13, issue.8, pp.1922-1932, 1995. ,
DOI : 10.1200/JCO.1995.13.8.1922
Individual Quality Assessment Of Autografting By Probability Estimation For Clinical End-Points: A Prospective Validation Study Of The European Blood And Marrow Transplantation (Ebmt), Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 2013. ,
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission, Blood, vol.116, issue.17, pp.3157-3162, 2010. ,
DOI : 10.1182/blood-2009-11-252197
Where do we stand with respect to the use of peripheral blood progenitor cells?, Annals of Oncology, vol.5, issue.9, pp.781-784, 1994. ,
DOI : 10.1093/oxfordjournals.annonc.a059003
Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy, Journal of Clinical Oncology, vol.18, issue.6, pp.1360-1377, 2000. ,
DOI : 10.1200/JCO.2000.18.6.1360
Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival., Journal of Clinical Investigation, vol.59, issue.4, pp.625-632, 1977. ,
DOI : 10.1172/JCI108680
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose, Blood. 1 juin, vol.89, issue.11, pp.4226-4235, 1997. ,
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation, Blood, vol.100, issue.12, pp.3930-3934, 2002. ,
DOI : 10.1182/blood-2002-01-0339
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation, Leukemia, vol.75, issue.5, pp.869-875, 2003. ,
DOI : 10.1056/NEJM198106183042507
Allogeneic transplantation of CD34+ selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34+ cells?, Blood, vol.98, issue.8, pp.2352-2357, 2001. ,
DOI : 10.1182/blood.V98.8.2352
CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies, Blood. 15 oct, vol.88, issue.8, pp.3223-3229, 1996. ,
Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia, Bone Marrow Transplantation, vol.95, issue.6, pp.575-580, 2001. ,
DOI : 10.1200/JCO.2000.18.3.537
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation, Blood, vol.99, issue.8, pp.2726-2733, 2002. ,
DOI : 10.1182/blood.V99.8.2726
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation, The Lancet, vol.341, issue.8858, p.1482, 1993. ,
DOI : 10.1016/0140-6736(93)90929-B
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation, Blood, vol.99, issue.8, pp.2726-2733, 2002. ,
DOI : 10.1182/blood.V99.8.2726
Automated hematology analysers and spurious counts Part 2. Leukocyte count and differential], Ann Biol Clin avr, vol.70, issue.2, pp.141-154, 2012. ,
Comparison of Single- and Dual-Platform Approaches to Enumerate CD34+ Cells in Bone Marrow and Mobilized Peripheral Blood Stem Cells, Archives of Medical Research, vol.34, issue.1, pp.16-19, 2003. ,
DOI : 10.1016/S0188-4409(02)00451-4
Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumeration, Clinical and Laboratory Haematology, vol.21, issue.5, pp.337-346, 1999. ,
DOI : 10.1046/j.1365-2257.1999.00236.x
Positive selection for CD34 + reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation, Experimental Hematology, vol.31, issue.6, pp.545-550, 2003. ,
DOI : 10.1016/S0301-472X(03)00070-5
ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery, Transfusion, vol.45, issue.3, pp.398-402, 2006. ,
DOI : 10.1046/j.1537-2995.2003.00465.x
Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components, Bone Marrow Transplantation, vol.141, issue.7, pp.749-757, 2000. ,
DOI : 10.1111/j.1600-0609.1986.tb01763.x
Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood versus bone marrow stem cells, N Engl J Med. 17 janv, vol.368, issue.3, p.288, 2013. ,